Mihue Jang

Mihue Jang is a Principal Research Scientist at the Korea Institute of Science and Technology (KIST), specializing in NK cell–based immunotherapy and next-generation CAR-NK platforms. Her research focuses on developing non-viral engineering strategies, including circRNA-based CAR systems, to enable scalable and safe immune cell therapies. She has contributed to advancing approaches that overcome key challenges in solid tumors, such as antigen shedding and tumor microenvironment–mediated suppression. Her work also extends to expanding NK cell therapeutics into fibrotic and autoimmune diseases. Dr. Jang has led multiple translational research programs and serves as a corresponding author on publications in high-impact journals including Signal Transduction and Targeted Therapy, Theranostics, and Biomaterials.